Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge assists in connection with the acquisition of Alergovet S.L.
Mandate

Vinge assists in connection with the acquisition of Alergovet S.L.

December 14, 2016

Vinge assists Nextmune Holding B.V., primarily owned by Fidelio Capital and Premune, in connection with the acquisition of the shares in Alergovet S.L. Alergovet is a leading company in Southern Europe focused on the diagnoses and treatment of atopic dermatitis for companion animals and horses, and offers high quality allergy tests and allergen-specific immunotherapy treatment for companion animals and horses.

Vinge’s team consists of partner Jonas Johansson together with, among others, associates Albert Wållgren, Linn Adelwald, Isabell Nielsen, Andréa Nicolin, Gustav Tengblad and Sofia Bergenstråhle.

Related

Vinge has advised Gamma Waves on Sportway’s EUR 20 million financing round

 Vinge has acted as legal adviser to Gamma Waves in connection with Sportway’s EUR 20 million financing round. The round was led by Gamma Waves, together with continued participation from existing shareholders, and values Sportway at approximately EUR 92 million (around SEK 1 billion) post-money.
June 24, 2026

Vinge advises Spotlight Group in connection with offer from Kriptown

 Vinge is advising Spotlight Group AB (publ) in connection with Kriptown SAS having made a public cash takeover offer to the shareholders of Spotlight Group
June 17, 2026

Vinge has advised EQT IX in connection with its exit of Beijer Ref AB (publ)

 Vinge has advised EQT IX (”EQT”) in connection with the sale of all of its remaining shares of series B in Beijer Ref AB (publ) through an accelerated bookbuilding process carried out on 15 June 2026.
June 16, 2026